Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes

Eran Zilberberg, Jigal Haas, Shir Dar, Alon Kedem, Ronit Machtinger, Raoul Orvieto

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Abstract

Objective: Human chorionic gonadotropin (hCG) is usually used at the end of controlled ovarian hyperstimulation (COH), as a surrogate LH surge, to induce final oocyte maturation and resumption of meiosis. Recently, the co-administration of GnRH agonist and hCG for final oocyte maturation - 40 and 34 h prior to OPU, respectively (double trigger) was suggested to improve IVF outcome in patient with genuine empty follicle syndrome. In the present study, we aim to evaluate whether the double trigger might improve the proportions of metaphase-II (MII) oocytes in patients with low proportion of mature oocytes (<66%) per number oocytes retrieved. Patients and methods: We compared the stimulation characteristics of 12 IVF cycles, which include the cycle with the double trigger to the same patients' previous IVF attempt, triggered with hCG-only. Results: Patients who received the double trigger (study group) had a significantly higher number of mature oocytes - MII (6.5 versus 3.6 p<0.008), number of embryos transferred (2.4 versus 1.1 p<0.03), a significantly higher proportions of MII oocytes per number of oocytes retrieved (69.7% versus 47.1% p<0.03) and a higher number of top quality embryos (3.1 versus 1 p50.02), as compared to their previous control cycles (hCG-only trigger). Six pregnancies were recorded in the study group and none in the control group. Conclusions: Co-administration of GnRH-agonist and hCG for final oocyte maturation, 40 and 34 h prior to OPU, respectively (double trigger) improves IVF outcome in patients with high proportion of immature oocytes.

Original languageEnglish
Pages (from-to)145-147
Number of pages3
JournalGynecological Endocrinology
Volume31
Issue number2
DOIs
StatePublished - 1 Feb 2015
Externally publishedYes

Keywords

  • Final oocyte maturation
  • GnRH-agonist
  • GnRH-antagonist
  • HCG
  • IVF outcome
  • Oocytes retrieval

Fingerprint

Dive into the research topics of 'Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes'. Together they form a unique fingerprint.

Cite this